Preview

Complex Issues of Cardiovascular Diseases

Advanced search

Risk factors for the occurrence of typical atrial flutter in patients undergoing pulmonary vein isolation

https://doi.org/10.17802/2306-1278-2021-10-2-8-15

Abstract

Highlights. Cavatricuspid isthmus ablation with pulmonary vein isolation is indicated to all patients with documented or intraoperatively induced typical atrial flutter. The preventive cavatricuspid isthmus ablation remains an issue of concern. The article discusses the risk factors for the onset of typical atrial flutter pulmonary vein isolation.

Aim. To determine the need for preventive ablation of the cavatricuspid isthmus in patients referred to elective pulmonary vein isolation.

Methods. 632 patients (the mean age of 63 years) were enrolled in a single-center retrospective study between 2015 to 2018. The inclusion criteria were as follows: paroxysmal AF, absence of documented AFL. All patients underwent pulmonary vein isolation. The exclusion criteria were as follows: a history of typical or AFL. The endpoints included major cardiovascular events, reoperations, occurrence of AFL. The primary endpoint was the absence of paroxysms of AF and AFL during the blind period. The secondary endpoint was the absence of AF paroxysms documented on the ECG or according to Holter monitoring data. The follow-up period was 12 months.

Results. During the blind period, AF paroxysms were recorded in 148 (23.7%) patients. The efficiency of the operation within one year was 78.2% (494 patients). 138 patients (21.8%) had recurrent tachycardia. Of them, 28 patients (4.4%) were diagnosed with atrial fibrillation and others (17.4%) had AFL. Risk factors for AFL included COPD found in 18 patients (64.29%) (OR 25.4; CI 95%; 10.991-58.609), chronic heart failure in 20 patients (71.43%) (OR 7.434; CI 95%; 3.209-17.225), prolonged pr interval in 18 patients (64.29%) (OR 5.77; CI 95%; 2.288-14.5), a history of myocardial infarction in 6 patients (28.57%) (OR 6.591; CI 95%; 2.447-17.751), and smoking in 7 patients (67.86%) (OR 11.034; CI 95%; 4.849-25.112).

Conclusion. Chronic obstructive pulmonary disease, chronic heart failure, a history of myocardial infarction, and smoking prolong right atrial conduction time, thereby increasing the risk of AFL in the postoperative period. Preventive cavatricuspid isthmus ablation should be considered in patients with risk factors for developing AFL.

About the Authors

N. V. Safonov
Peoples' Friendship University of Russia
Russian Federation

Safonov Nikita V. - a postgraduate student at the Department of Hospital Surgery, Medical Institute, Peoples' Friendship University of Russia.

6, Miklukho-Maklaya St., Moscow, 117198.


Competing Interests:

No



V. Yu. Baranovich
Peoples' Friendship University of Russia
Russian Federation

Baranovich Vladislav Yu. - Associate Professor at the Department of Hospital Surgery, Medical Institute, Peoples' Friendship University of Russia.

6, Miklukho-Maklaya St., Moscow, 117198.


Competing Interests:

No



A. G. Faibushevich
Peoples' Friendship University of Russia
Russian Federation

Faibushevich Alexander G. - Head of the Department of Hospital Surgery, Medical Institute, Peoples' Friendship University of Russia.

6, Miklukho-Maklaya St., Moscow, 117198.


Competing Interests:

No



References

1. Strutynskij A. V. Elektrokardiogramma. Analiz i interpretaciya. Moscow: MEDpress-inform; 2009. 224 p. (in Russian).

2. Pappone C., Rosanio S., Augello G., Gallus G., Vicedomini G., Mazzone P., Gulletta S., Gugliotta F., Pappone A., Santinelli V., Tortoriello V., Sala S., Zangrillo A., Crescenzi G., Benussi S., Alfieri O.J. Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: outcomes from a controlled nonrandomized longterm study. Am Coll Cardiol. 2003; 42(2):185-97. doi: 10.1016/s0735-1097(03)00577-1.

3. Hsu L.F., Jais P., Keane D., Wharton J.M., Deisenhofer I., Hocini M., Shah D.C., Sanders P., Scavee C., Weerasooriya R., Clementy J., Haissaguerre M. Atrial fibrillation originating from persistent left superior vena cava. Circulation. 2004 Feb 24;109(7):828-32. doi: 10.1161/01.CIR.0000116753.56467.BC.

4. Wyndham C.R.C. Atrial Fibrillation: The Most Common Arrhythmia. Tex Heart Inst J. 2000; 27(3): 257-267.

5. Perez F.J., Schubert C.M., Parvez B., Pathak V., Ellenbogen K.A., Wood M.A. Long-term outcomes after catheter ablation of cavo-tricuspid isthmus dependent atrial flutter: a metaanalysis. Circ Arrhythm Electrophysiol. 2009;2(4):393-401. doi: 10.1161/CIRCEP.109.871665.

6. January C.T., Wann L.S., Calkins H., Chen L.Y., Cigarroa J.E., Cleveland J.C. Jr., Ellinor P.T., Ezekowitz M.D., Field M.E., Furie K.L., Heidenreich P.A., Murray K.T., Shea J.B., Tracy C.M., Yancy C.W. 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2019;74(1):104-132. doi: 10.1016/j.jacc.2019.01.011.

7. Mesquita J., Ferreira A.M., Cavaco D., Carmo P., Madeira M., Freitas P, Costa F.M., Morgado F., Mendes M., Adragao P Impact of prophylactic cavotricuspid isthmus ablation in atrial fibrillation recurrence after a first pulmonary vein isolation procedure. Int J Cardiol. 2018;259:82-87. doi: 10.1016/j.ijcard.2018.01.025.

8. Rahman F., Wang N., Yin X., Ellinor P.T., Lubitz S.A., LeLorier P.A., McManus D.D., Sullivan L.M., Seshadri S., Vasan R.S., Benjamin E.J., Magnani J.W. Atrial flutter: Clinical risk factors and adverse outcomes in the Framingham Heart Study. Heart Rhythm. 2016 Jan;13(1):233-40. doi: 10.1016/j.hrthm.2015.07.031

9. Hayashi T., Fukamizu S., Hojo R., Komiyama K., Tanabe Y., Tejima T., Nishizaki M., Hiraoka M., Ako J., Momomura S., Sakurada H. Prevalence and electrophysiological characteristics of typical atrial flutter in patients with atrial fibrillation and chronic obstructive pulmonary disease. Europace. 2013 Dec;15(12):1777-83. doi: 10.1093/europace/eut158.

10. Garci'a-Cosi'o F., Pastor Fuentes A., Nunez Angulo A.. Arrhythmias (IV). Clinical approach to atrial tachycardia and atrial flutter from an understanding of the mechanisms. Electrophysiology based on anatomy. Rev Esp Cardiol (Engl Ed). 2012;65(4):363-75. doi: 10.1016/j.recesp.2011.11.020.

11. Ohkubo K., Watanabe I., Okumura Y., Ashino S., Kofune M., Kawauchi K., Yamada T., Kofune T., Hashimoto K., Shindo A., Sugimura H., Nakai T., Kunimoto S., Saito S., Hirayama A. Anatomic and electrophysiologic differences between chronic and paroxysmal atrial flutter: intracardiac echocardiographic analysis. Pacing Clin Electrophysiol. 2008;31(4):432-7. doi: 10.1111/j.1540-8159.2008.01012.x.

12. Granada J., Uribe W., Chyou P.H., Maassen K., Vierkant R., Smith P.N., Hayes J., Eaker E., Vidaillet H. Incidence and predictors of atrial flutter in the general population. J Am Coll Cardiol. 2000 Dec;36(7):2242-6. doi: 10.1016/s0735-1097(00)00982-7.

13. Dizon J., Biviano A., Whang W., Ehlert F., Garan H. Changes in low right atrial conduction times during pulmonary vein isolation for atrial fibrillation: correlation with inducibility of typical right atrial flutter. Europace. 2011 Jul;13(7):942-8. doi: 10.1093/europace/eur033.


Review

For citations:


Safonov N.V., Baranovich V.Yu., Faibushevich A.G. Risk factors for the occurrence of typical atrial flutter in patients undergoing pulmonary vein isolation. Complex Issues of Cardiovascular Diseases. 2021;10(2):8-15. (In Russ.) https://doi.org/10.17802/2306-1278-2021-10-2-8-15

Views: 491


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2306-1278 (Print)
ISSN 2587-9537 (Online)